Article
Plasma cell leukemia: update on biology and therapy.
Leukemia & lymphoma - 1 Jul 2017
Mina Roberto, D'Agostino Mattia, Cerrato Chiara, Gay Francesca, Palumbo Antonio
Abstract excerpt
Plasma cell leukemia (PCL) is a rare, but very aggressive, plasma cell dyscrasia, representing a distinct clinicopathological entity as compared to multiple myeloma (MM), with peculiar biological and clinical features. A hundred times rarer than MM, the disease course is characterized by short remissions and poor survival. PCL is defined by an increased percentage (>20%) and absolute number (>2 × 109/l) of plasma...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
